Clinical Trial Update: Evaluation of the Archimedes™ System for Transparenchymal Nodule Access [NA]

View source ↗

Summary

Clinical trial update indicates the Archimedes System trial for transparenchymal nodule access in lung cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Broncus Medical Inc | Conditions: Lung Cancer | NA | Status: TERMINATED